CA Stocks

HASH.V Stock Surges 28.6% in Pre-Market Trading on May 1

Key Points

HASH.V stock surges 28.6% to $0.045 CAD in pre-market trading.

Simply Solventless Concentrates trades at steep valuation discount with PE of 0.75.

Strong technical oversold conditions and 2.86x average volume drive buying pressure.

Meyka AI rates stock B with neutral recommendation and $0.06 monthly price target.

Be the first to rate this article

HASH.V stock is making waves in pre-market trading on May 1, 2026, with a powerful 28.6% surge that has caught investor attention. Simply Solventless Concentrates Ltd., the Calgary-based cannabis concentrate manufacturer, pushed the stock price to $0.045 CAD on the TSX. Trading volume hit 684,486 shares, nearly triple the average daily volume of 296,536. This sharp move reflects renewed interest in the company’s solventless concentrate portfolio for recreational, medical, and B2B cannabis markets across Canada. The momentum signals potential shifts in market sentiment around the stock.

HASH.V Stock Price Action and Market Movement

HASH.V stock opened at $0.035 CAD and climbed to a day high of $0.045 CAD, marking the 28.6% gain in pre-market trading. The stock bounced off its 52-week low of $0.035, showing buyers stepping in at support levels. Market cap sits at $5.2 million CAD with 115.5 million shares outstanding.

Technical Setup and Price Levels The stock trades well below its 52-week high of $0.51 CAD, indicating a significant recovery opportunity if momentum sustains. The 50-day moving average sits at $0.0611, while the 200-day average is $0.18523. This positioning suggests the stock is trading below both key moving averages, which could attract value-focused traders. Bollinger Bands show the stock near the lower band at $0.03, indicating potential oversold conditions that may have triggered today’s bounce.

Simply Solventless Concentrates Business and Sector Position

Simply Solventless Concentrates Ltd. operates in the Healthcare sector under the Drug Manufacturers – Specialty & Generic industry classification. The company cultivates, processes, formulates, manufactures, and sells terpene-rich solventless concentrates for Canada’s cannabis market. CEO Jeffrey Swainson leads operations from the company’s Calgary headquarters at 888 3rd Street SW.

Financial Metrics and Valuation The company trades at a PE ratio of 0.75, significantly below the Healthcare sector average of 16.64, suggesting potential undervaluation. EPS stands at $0.06 CAD, while the price-to-sales ratio is just 0.17, indicating the stock trades at a steep discount to revenue. The current ratio of 2.53 shows solid short-term liquidity, though negative operating cash flow of -$0.0163 per share raises operational concerns. Track HASH.V on Meyka for real-time updates and detailed financial tracking.

Market Sentiment and Trading Activity

Pre-market volume of 684,486 shares represents 2.86x the average daily volume, signaling strong institutional and retail interest. The relative volume spike suggests news or technical factors are driving the buying pressure today.

Trading Activity and Liquidation Dynamics The Money Flow Index (MFI) reads 66.67, indicating strong buying pressure and potential accumulation by smart money. The Relative Strength Index (RSI) at 47.0 sits near neutral territory, suggesting room for further upside if momentum continues. Stochastic indicators (%K and %D both at 33.33) show the stock is oversold on shorter timeframes, which often precedes bounces. The Awesome Oscillator at -0.01 remains slightly negative, but the combination of technical signals suggests buyers are testing resistance levels aggressively.

Meyka AI Rating and Forward Outlook

Meyka AI rates HASH.V with a grade of B, reflecting a neutral recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating score of 63.2 out of 100 indicates the stock sits in middle territory with mixed fundamental signals.

Forecast and Risk Considerations Meyka AI’s forecast model projects a monthly price target of $0.06 CAD, implying 33% upside from current levels. This represents a meaningful recovery if the model’s assumptions hold. However, forecasts are model-based projections and not guarantees. The company faces headwinds including negative operating cash flow and a debt-to-equity ratio of 0.48. Earnings are scheduled for announcement on May 6, 2026, which could provide clarity on operational performance and future direction. These grades are not guaranteed and we are not financial advisors.

Final Thoughts

HASH.V stock surged 28.6% in pre-market trading, driven by attractive valuations with a PE ratio of 0.75 and price-to-sales of 0.17. While these metrics appeal to contrarian investors, operational concerns including negative cash flow and recovery from 52-week lows present risks. The May 6 earnings announcement will be crucial for confirming this momentum. Micro-cap cannabis stocks are volatile and require careful risk management due to sharp price swings on low volume.

FAQs

Why did HASH.V stock jump 28.6% in pre-market trading?

HASH.V surged on strong buying pressure with volume nearly triple the average. Technical oversold conditions, combined with the stock trading well below its 52-week high of $0.51, likely triggered accumulation by value-focused buyers seeking recovery plays.

What is Simply Solventless Concentrates’ business model?

The company cultivates, processes, and manufactures terpene-rich solventless cannabis concentrates for recreational, medical, and B2B markets in Canada. Based in Calgary, it operates in the specialty drug manufacturing sector under Healthcare classification.

Is HASH.V stock undervalued based on current metrics?

HASH.V trades at a PE ratio of 0.75 and price-to-sales of 0.17, both significantly below Healthcare sector averages. However, negative operating cash flow and high inventory levels suggest operational challenges that may justify the discount.

When is the next earnings announcement for HASH.V?

Simply Solventless Concentrates is scheduled to announce earnings on May 6, 2026, at 4:00 PM EDT. This report will provide critical insights into revenue, profitability, and cash flow trends that could validate or challenge today’s momentum.

What does Meyka AI’s B grade mean for HASH.V?

The B grade with a neutral recommendation indicates mixed fundamentals. Meyka AI projects $0.06 monthly price target, implying 33% upside. However, forecasts are model-based projections and not guaranteed. Conduct your own research before investing.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)